首页 | 本学科首页   官方微博 | 高级检索  
     


Allosteric rescuing of loss-of-function FFAR2 mutations
Authors:Gayathri Swaminath  Peter Jaeckel  Qi Guo  Jennifer Weiszmann  Yingcai Wang  Yang Li
Affiliation:a Amgen Inc., 1120 Veterans Blvd., South San Francisco, CA 94080, United States
b Amgen Research-GMBH, Regensburg, Germany
Abstract:FFAR2 (GPR43) is a receptor for short-chain fatty acids (SCFAs), acetate and propionate. In the current study, we investigate the molecular determinants contributing to receptor activation by endogenous ligands. Mutational analysis revealed several important residues located in transmembrane domains (TM) 3, 4, 5, 6, and 7 for acetate binding. Interestingly, mutations that abolished acetate activity, including the mutation in the well-conserved D(E)RY motif, could be rescued by a recently identified synthetic allosteric agonist. These findings provide additional insight into agonist binding and activation which may aid in designing allosteric ligands for targeting receptor function in various diseases.
Keywords:Free fatty acid receptor 2   FFA2   GPR43   Allosteric agonist   Short-chain fatty acids   AMG7703
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号